((自动化翻译由路透提供，请见免责声明 ))
10月23日 - ** 药物开发商Tevogen Bio 股价上涨84.5%，创下2.97美元的逾六个月新高
** 该公司称其人工智能项目 (link)，Tevogen AI，已经与微软 在微软初创企业项目下建立了合作伙伴关系。
** TVGN表示，双方的合作将为其提供进入微软广泛生态系统的机会
** 合作将加速和简化 Tevogen 专有算法的开发，极大地推进我们降低药物开发总成本、加快药物发现的使命。
** 麦肯锡全球研究院称，人工智能每年可为制药和医疗技术公司创造 600 亿至 1100 亿美元的经济价值，其中仅商业功能就可创造 180 亿至 300 亿美元的价值 - TVGN
** Tevogen AI 的首席信息官 Mittul Mehta 曾在 MSFT 工作。
** 今年以来，TVGN股价下跌了78%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.